TRIM9
Basic information
Region (hg38): 14:50975262-51096061
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRIM9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 32 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 32 | 1 | 0 |
Variants in TRIM9
This is a list of pathogenic ClinVar variants found in the TRIM9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-50979451-G-C | not specified | Uncertain significance (Aug 12, 2024) | ||
14-50979477-A-C | not specified | Uncertain significance (Jan 29, 2024) | ||
14-50979517-A-G | not specified | Uncertain significance (Aug 08, 2022) | ||
14-50981836-C-T | not specified | Uncertain significance (Jun 16, 2024) | ||
14-50981868-G-T | not specified | Uncertain significance (Jan 17, 2024) | ||
14-50982074-C-T | not specified | Uncertain significance (May 28, 2024) | ||
14-50998073-G-A | not specified | Uncertain significance (Oct 27, 2022) | ||
14-50998094-C-A | not specified | Uncertain significance (Jan 20, 2023) | ||
14-50998110-C-A | not specified | Uncertain significance (Dec 27, 2022) | ||
14-51000689-T-G | not specified | Uncertain significance (Nov 15, 2021) | ||
14-51000733-C-T | not specified | Uncertain significance (Jul 12, 2023) | ||
14-51009085-A-C | not specified | Uncertain significance (Nov 07, 2023) | ||
14-51009125-G-A | not specified | Uncertain significance (Dec 04, 2024) | ||
14-51009178-C-T | not specified | Uncertain significance (Mar 24, 2023) | ||
14-51009185-C-T | not specified | Uncertain significance (Apr 15, 2022) | ||
14-51022866-C-T | not specified | Uncertain significance (Dec 06, 2024) | ||
14-51022869-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
14-51022906-T-C | not specified | Uncertain significance (May 24, 2024) | ||
14-51022951-T-C | not specified | Uncertain significance (Oct 27, 2022) | ||
14-51025287-C-T | not specified | Uncertain significance (Mar 04, 2024) | ||
14-51025303-A-G | not specified | Uncertain significance (Jan 20, 2023) | ||
14-51025335-C-G | not specified | Uncertain significance (Apr 09, 2024) | ||
14-51025336-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
14-51094153-C-G | not specified | Uncertain significance (Apr 04, 2023) | ||
14-51094204-T-C | not specified | Uncertain significance (Sep 12, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRIM9 | protein_coding | protein_coding | ENST00000298355 | 10 | 120800 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000267 | 125744 | 0 | 2 | 125746 | 0.00000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.01 | 241 | 413 | 0.583 | 0.0000223 | 4673 |
Missense in Polyphen | 57 | 122.82 | 0.46408 | 1395 | ||
Synonymous | 0.564 | 166 | 176 | 0.946 | 0.0000107 | 1393 |
Loss of Function | 4.72 | 1 | 28.0 | 0.0358 | 0.00000127 | 326 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000879 | 0.00000879 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase which ubiquitinates itself in cooperation with an E2 enzyme UBE2D2/UBC4 and serves as a targeting signal for proteasomal degradation. May play a role in regulation of neuronal functions and may also participate in the formation or breakdown of abnormal inclusions in neurodegenerative disorders. May act as a regulator of synaptic vesicle exocytosis by controlling the availability of SNAP25 for the SNARE complex formation. {ECO:0000269|PubMed:20085810}.;
- Pathway
- Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
(Consensus)
Recessive Scores
- pRec
- 0.172
Intolerance Scores
- loftool
- 0.0372
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.51
Haploinsufficiency Scores
- pHI
- 0.259
- hipred
- Y
- hipred_score
- 0.818
- ghis
- 0.592
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.981
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trim9
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype;
Gene ontology
- Biological process
- synaptic vesicle exocytosis;protein ubiquitination;negative regulation of SNARE complex assembly;proteasome-mediated ubiquitin-dependent protein catabolic process;negative regulation of calcium ion-dependent exocytosis
- Cellular component
- cytoplasm;cytosol;cytoskeleton;synaptic vesicle;cell junction;dendrite;presynaptic cytosol
- Molecular function
- SNARE binding;ubiquitin-protein transferase activity;protein binding;zinc ion binding;protein domain specific binding;protein homodimerization activity